Profil
David Gibson currently serves as the Chief Financial Officer of UPMC Enterprises.
Within this role, he is responsible for all finance and accounting related matters for the organization while supporting its portfolio of health care focused companies, technologies, and solutions.
Prior to joining UPMC Enterprises, David had multiple financial leadership positions at both private and public health care companies, including Director of Finance at Precision Therapeutics, Inc. and Controller at Philips Children’s Medical Ventures.
David began his career at Deloitte within their Audit and Assurance group.
David received his B.S.
in Business Administration from Bucknell University and is a Certified Public Accountant.
Postes actifs de David Gibson
| Sociétés | Poste | Début |
|---|---|---|
UPMC Enterprises
UPMC Enterprises Investment ManagersFinance UPMC Enterprises invests in companies located across the globe. The firm targets companies operating in the fields of health care and technology sectors. It provides financing for early and later-stage transactions. | Directeur Financier/CFO | 01/11/2019 |
Anciens postes connus de David Gibson
| Sociétés | Poste | Fin |
|---|---|---|
Helomics Corp.
Helomics Corp. Medical/Nursing ServicesHealth Services Provides cancer care development and treatment consulting services | Directeur Financier/CFO | 31/05/2015 |
Formation de David Gibson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Bucknell University
Bucknell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Helomics Corp.
Helomics Corp. Medical/Nursing ServicesHealth Services Provides cancer care development and treatment consulting services | Health Services |
UPMC Enterprises
UPMC Enterprises Investment ManagersFinance UPMC Enterprises invests in companies located across the globe. The firm targets companies operating in the fields of health care and technology sectors. It provides financing for early and later-stage transactions. | Finance |
















